• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Report: FDA promise of 1 million coronavirus tests this week unattainable

Report: FDA promise of 1 million coronavirus tests this week unattainable

March 3, 2020 By Nancy Crotti

(Image from the CDC)

The FDA grossly overestimated the number of coronavirus diagnostic tests that would be available this week as well as U.S. laboratories’ capacity to process them, according to a report in the New York Times.

FDA commissioner Stephen Hahn told reporters on Monday that the agency’s decision allowing private labs to make their own tests would broaden their capacity to perform those tests, the Times report said.

The agency on Feb. 4 authorized the emergency use of a coronavirus test at the request of the Centers for Disease Control and Prevention (CDC). That test is manufactured by Integrated DNA Technologies, but increased production does not affect laboratories’ capacity to conduct the testing, the Times reported. New guidance the FDA issued on Feb. 29 allows any CLIA-certified, high-complexity laboratory to go through the process to become certified to test.

Scott Becker, CEO of the Association of Public Health Laboratories, said on Saturday that his organization expects public health laboratories will have the capacity to conduct 10,000 tests a day by the end of this week.  On Monday, Becker dialed that back, saying that labs can conduct about 100 tests per day, but that only half of them have the capacity to do so, the Times reported.

An apparent manufacturing defect in the initial tests rolled out by the CDC has caused a delay in upping the supply of tests, according to a report by Politico. The U.S. Department of Health and Human Services is  investigating the problem.

 

Filed Under: Diagnostics, Featured, Food & Drug Administration (FDA), Lab Instruments & Supplies, Regulatory/Compliance Tagged With: Centers for Disease Control & Prevention (CDC), coronavirus, FDA, integrated dna technologies

More recent news

  • Johnson & Johnson MedTech launches new Volt plating systems for radius, humerus
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump
  • Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor
  • Anaconda Biomed wins CE mark for funnel catheter
  • FDA approves Neuspera neuromod for urinary incontinence

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy